These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19107438)

  • 1. Molecular epidemiology of DNA repair genes in bladder cancer.
    Kiltie AE
    Methods Mol Biol; 2009; 472():281-306. PubMed ID: 19107438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene polymorphisms in bladder cancer.
    Franekova M; Halasova E; Bukovska E; Luptak J; Dobrota D
    Urol Oncol; 2008; 26(1):1-8. PubMed ID: 18190823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2537-41. PubMed ID: 17164382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.
    Malats N
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
    Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
    Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.
    Lin J; Kadlubar FF; Spitz MR; Zhao H; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1832-6. PubMed ID: 16030125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions.
    Horikawa Y; Gu J; Wu X
    Curr Opin Urol; 2008 Sep; 18(5):493-8. PubMed ID: 18670273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
    Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and genetic susceptibility to bladder cancer.
    Wu X; Ros MM; Gu J; Kiemeney L
    BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common predisposition alleles for moderately common cancers: bladder cancer.
    Kiltie AE
    Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.
    Vineis P; Manuguerra M; Kavvoura FK; Guarrera S; Allione A; Rosa F; Di Gregorio A; Polidoro S; Saletta F; Ioannidis JP; Matullo G
    J Natl Cancer Inst; 2009 Jan; 101(1):24-36. PubMed ID: 19116388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
    Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
    Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogen exposure and epigenetic silencing in bladder cancer.
    Marsit CJ; Karagas MR; Schned A; Kelsey KT
    Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide excision repair, oxidative damage, DNA sequence polymorphisms, and cancer treatment.
    Hutsell SQ; Sancar A
    Clin Cancer Res; 2005 Feb; 11(4):1355-7. PubMed ID: 15746031
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives on the molecular epidemiology of aerodigestive tract cancers.
    Hung RJ; van der Hel O; Tavtigian SV; Brennan P; Boffetta P; Hashibe M
    Mutat Res; 2005 Dec; 592(1-2):102-18. PubMed ID: 16023150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications.
    Wu X; Hildebrandt MA; Chang DW
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):269-80. PubMed ID: 20016998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bladder cancer and occupational activity].
    Porru S; Scotto di Carlo A; Carta A; Placidi D
    G Ital Med Lav Ergon; 2003; 25(3):298-300. PubMed ID: 14582243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.